IVD3: IVDR: Current state

By Mehryar Behizad2023-12-05T16:00:00

The first speaker was Olga Tkachenko from the European Commission and MDCG. She spoke about progress of the In Vitro Diagnostics Regulation (IVDR). Outlining the timeline, she reiterated the current transition calendar for IVDR and outlined the European Commission’s workstreams on IVDR and MDR transitions and its interactions with MDCG, EMA and competent authorities. Tkachenko then covered the MDCG’s focus on transition and availability of devices and discussed the points explained in MDCG-2022-14 position paper and the IVDR joint implementation plan, published in June, which is in the process of being updated.

How to read this journal article

Thank you for visiting Regulatory Rapporteur. Journal articles are restricted to registered users and TOPRA members.

Already a member or have an account? Sign in.

1. REGISTER FOR FREE

Free access to selected content

Register now to continue to access industry news, editorials and podcasts plus one member-only journal article each month.

Create your own library to save your favourite content.

Create a free account

2. Members login

Already a TOPRA member?

Log-in now using your MyTOPRA credentials, for unlimited access to all Regulatory Rapporteur journal articles, the online archive and latest industry news and podcasts.

3. JOIN TOPRA

Special offer on
TOPRA membership

Join TOPRA today and get membership until the end of 2025 for the exclusive rate of £290.

In addition to unlimited access to Regulatory Rapporteur content, as a TOPRA member you will also be able to enjoy a wide range of benefits including career boosting resources, savings on our events and training, and access to our regional networks and special interest groups.

This offer ends 31 July 2024

Become a member